Efficacy and Safety of Luspatercept in Patients Enrolled in the BELIEVE Trial: Data from the Phase 3b Long-Term Rollover Study

被引：2
|
作者：
Cappellini, Maria Domenica [1 ]
Taher, Ali T. [2 ]
Viprakasit, Vip [3 ]
Georgiev, Pencho [4 ]
Kuo, Kevin H. M. [5 ,6 ]
Holot, Natalia [7 ]
Vilmont, Valerie [8 ]
Medlin, Loyse Felber [8 ]
Kuo, Wen-Ling [7 ]
Lai, Yinzhi [7 ]
Bueno, Luciana Moro [8 ]
Sheth, Sujit [9 ]
机构：
[1] Univ Milan, Fdn IRCCS Ca Granda Policlin Hosp, Milan, Italy
[2] Amer Univ, Dept Internal Med, Beirut Med Ctr, Beirut, Lebanon
[3] Mahidol Univ, Siriraj Res Hosp, Bangkok, Thailand
[4] Med Univ Plovdiv, Plovdiv, Bulgaria
[5] Univ Hlth Network, Div Med Oncol & Hematol, Dept Med, Toronto, ON, Canada
[6] Univ Toronto, Div Hematol, Dept Med, Toronto, ON, Canada
[7] Bristol Myers Squibb, Princeton, NJ USA
[8] Bristol Myers Squibb Co, Celgene Int Sarl, Boudry, Switzerland
[9] Weill Cornell Med, Div Pediat Hematol Oncol, New York, NY USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-174089
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Long-Term Safety and Efficacy of Recombinant Coagulation Factor IX Albumin Fusion Protein (rIX-FP) in Previously Treated Pediatric Patients with Hemophilia B: Results from a Phase 3b Extension Study
    Kenet, Gili
    Chambost, Herve
    Male, Christoph
    Halimeh, Susan
    Lambert, Thierry
    Li, Yanyan
    Seifert, Wilfried
    Santagostino, Elena
    THROMBOSIS AND HAEMOSTASIS, 2020, 120 (04) : 599 - 606
  • [32] Long-Term Efficacy and Safety of Luspatercept in Lower-Risk Myelodysplastic Syndromes (MDS): Phase 2 PACE-MDS Study
    Platzbecker, Uwe
    Kiewe, Philipp
    Germing, Ulrich
    Goetze, Katharina
    Mayer, Karin
    Radsak, Markus
    Wolff, Thomas
    Chromik, Joerg
    Reynolds, Joseph
    Barron, Carolyn
    Zhang, Xiaosha
    Laadem, Abderrahmane
    Attie, Kenneth
    Giagounidis, Aristoteles
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S319 - S320
  • [33] Adalimumab long-term safety/efficacy results for pediatric patients with chronic plaque psoriasis from a phase 3, randomized study
    Papp, Kim
    Marcoux, Danielle
    Landells, Ian
    Weibel, Lisa
    Ghislain, Pierre-Dominique
    Unnebrink, Kristina
    Williams, David
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB209 - AB209
  • [34] EMBARK: A Phase 3b, Open-Label, Single-Arm, Safety Study to Evaluate the Long-Term Safety and Efficacy of Aducanumab in Eligible Participants With Alzheimer's Disease
    Castrillo-Viguera, Carmen
    Chalkias, Spyros
    Burkett, Patrick
    Wu, Shuang
    Chen, Huaihou
    Harrison, Katie
    Yurgalevitch, Carol
    Haeberlein, Samantha Budd
    NEUROLOGY, 2021, 96 (15)
  • [35] LONG-TERM SAFETY OF BUROSUMAB IN ADULTS WITH X-LINKED HYPOPHOSPHATAEMIA (XLH) IN A PHASE 3B OPEN-LABEL STUDY
    Javaid, M. K.
    Kamenicky, P.
    Roux, C.
    Lachman, R.
    Brandi, M. L.
    Cohen-Solal, M.
    Crowley, R.
    Ralston, S.
    Keen, R.
    Bowler, J.
    Henderson, L.
    Sun, W.
    Tudor, A.
    Quattrocchi, E.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S70 - S70
  • [36] A phase 3b, multicenter, open-label extension study of the long-term safety of anagrelide in Japanese adults with essential thrombocythemia
    Yuzuru Kanakura
    Yukari Shirasugi
    Hiroki Yamaguchi
    Michiaki Koike
    Takaaki Chou
    Shinichiro Okamoto
    Heinrich Achenbach
    Jingyang Wu
    Chiaki Nakaseko
    International Journal of Hematology, 2018, 108 : 491 - 498
  • [37] A phase 3b, multicenter, open-label extension study of the long-term safety of anagrelide in Japanese adults with essential thrombocythemia
    Kanakura, Yuzuru
    Shirasugi, Yukari
    Yamaguchi, Hiroki
    Koike, Michiaki
    Chou, Takaaki
    Okamoto, Shinichiro
    Achenbach, Heinrich
    Wu, Jingyang
    Nakaseko, Chiaki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2018, 108 (05) : 491 - 498
  • [38] Long-term intracranial safety and efficacy analyses from the phase III CROWN study
    Bearz, A.
    Felip, E.
    Mazieres, J.
    de Marinis, F.
    Bauer, T.
    Polli, A.
    Messina, R.
    Thurm, H.
    Thomaidou, D.
    Mok, T. S. K.
    Solomon, B. J.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S998 - S999
  • [39] Efficacy and safety of rIX-FP in surgery: An update from a phase 3b extension study
    Pan-Petesch, Brigitte
    Nagao, Azusa
    Karim, Faraizah Abdul
    Tosetto, Alberto
    Roman, Maria Teresa Alvarez
    Seifert, Wilfried
    Li, Yanyan
    Negrier, Claude
    THROMBOSIS RESEARCH, 2020, 193 : 139 - 141
  • [40] Long-Term Efficacy for Parkinsonism and Safety of Zonisamide in Patients with Dementia with Lewy Bodies: A Phase III Trial
    Toya, Shunji
    Murata, Miho
    Odawara, Toshinari
    Hasegawa, Kazuko
    Kajiwara, Ritsuko
    Takeuchi, Hisao
    Takai, Kentaro
    Kosaka, Kenji
    NEUROLOGY, 2019, 92 (15)
12345